Conference Coverage
Conference Coverage
Ablation for atrial fibrillation may protect the aging brain
Adults who had previously undergone catheter ablation were significantly less likely to be cognitively impaired during the 2-year study period,...
Conference Coverage
Meditation curbs stress, depression as adjunct to CAD rehab
Adding a meditation session also improved quality of life by 60% in coronary artery disease patients.
Conference Coverage
Racial disparities in cardiotoxicity after chemotherapy
“The most important message is to look at preexisting cardiovascular disease, oncology diagnosis, and be aware of existing disparities in a...
Conference Coverage
Napping and AFib risk: The long and the short of it
Both long and short daily naps were linked to atrial fibrillation risk, but in different ways.
Conference Coverage
Cardiovascular disease deaths rise on and after high-pollution days
High levels of air pollution were linked to higher risk of death from MI and stroke in a Polish population.
Conference Coverage
Seven ‘simple’ cardiovascular health measures linked to reduced dementia risk in women
Adherence to an American Heart Association guideline, even in part, modulated dementia risk.
Conference Coverage
COAPT 5-year results ‘remarkable,’ but patient selection issues remain
MitraClip’s success persisted throughout long-term follow-up in the trial, which entered patients with severe MR secondary to heart failure.
Conference Coverage
Dapagliflozin’s HFpEF benefit tied to lower filling pressure
Conference Coverage
LAA closure device shown safe in groups omitted in trials
New independent studies support safety of left atrial appendage closure devices in broad array of patient types.
Conference Coverage
Oral PCSK9 inhibitor shows encouraging LDL lowering
A new oral formulation of a PCSK9-inhibiting cholesterol-lowering drug has shown encouraging results in a phase 2 study.
Conference Coverage
‘Unheard of’ PAH improvement with novel drug: STELLAR
Sotatercept, a designer molecule that removes a key driver of pulmonary arterial hypertension, had efficacy and safety in the first of three...